173 related articles for article (PubMed ID: 37864310)
1. Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages.
Wu S; Lv X; Wei H; Chen W; Zheng J; Li X; Song J; Ai Y; Zou C
J Cell Mol Med; 2023 Dec; 27(24):4133-4144. PubMed ID: 37864310
[TBL] [Abstract][Full Text] [Related]
2. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
3. Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase
Gao F; Han J; Wang Y; Jia L; Luo W; Zeng Y
Cancer Biother Radiopharm; 2022 May; 37(4):233-245. PubMed ID: 32758011
[No Abstract] [Full Text] [Related]
4. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ_0008450 regulates the proliferation, migration, invasion, apoptosis and chemosensitivity of CDDP-resistant nasopharyngeal carcinoma cells by the miR-338-3p/SMAD5 axis.
Liu L; Lu B; Li Y
Anticancer Drugs; 2022 Jan; 33(1):e260-e272. PubMed ID: 34387609
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
Wang X; Li H; Shi J
Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
[TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_0049396 inhibited oral squamous cell carcinoma progression by regulating the miR-663b/ENDOU axis.
Lou Y; Ren L; Wang L
Genomics; 2023 Jan; 115(1):110553. PubMed ID: 36581129
[TBL] [Abstract][Full Text] [Related]
8. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
9. Circular RNA circ_0001017 Sensitizes Cisplatin-Resistant Gastric Cancer Cells to Chemotherapy by the miR-543/PHLPP2 Axis.
Zhang J; Zha W; Qian C; Ding A; Mao Z
Biochem Genet; 2022 Apr; 60(2):558-575. PubMed ID: 34313883
[TBL] [Abstract][Full Text] [Related]
10. Circular hsa_circ_0020377 regulates KLF7 by targeting miR-194-5p to facilitate tumor cell malignant behaviors and glycolysis in oral squamous cell carcinoma progression.
Hei N; Liu P; Jin L; Peng S; Bao Y
Funct Integr Genomics; 2023 Jan; 23(1):52. PubMed ID: 36717528
[TBL] [Abstract][Full Text] [Related]
11. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
Zhao M; Ma W; Ma C
Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
[TBL] [Abstract][Full Text] [Related]
12. Circ_0017274 acts on miR-637/CDX2 axis to facilitate cisplatin resistance in gastric cancer.
Xu B; Guo J; Chen M
Clin Exp Pharmacol Physiol; 2022 Oct; 49(10):1105-1115. PubMed ID: 35748299
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA hsa_circ_0000277 promotes tumor progression and DDP resistance in esophageal squamous cell carcinoma.
Cheng J; Zhang R; Yan M; Li Y
BMC Cancer; 2022 Mar; 22(1):238. PubMed ID: 35241028
[TBL] [Abstract][Full Text] [Related]
14. Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637.
Zheng X; Du F; Gong X; Xu P
Bioengineered; 2022 Jan; 13(1):440-454. PubMed ID: 34967281
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
[TBL] [Abstract][Full Text] [Related]
16. circ_SEPT9, a newly identified circular RNA, promotes oral squamous cell carcinoma progression through miR-1225/PKN2 axis.
Ai Y; Tang Z; Zou C; Wei H; Wu S; Huang D
J Cell Mol Med; 2020 Nov; 24(22):13266-13277. PubMed ID: 33090705
[TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated transfer of circ_0063526 enhances cisplatin resistance in gastric cancer cells via regulating miR-449a/SHMT2 axis.
Yang G; Tan J; Guo J; Wu Z; Zhan Q
Anticancer Drugs; 2022 Nov; 33(10):1047-1057. PubMed ID: 36206102
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
[TBL] [Abstract][Full Text] [Related]
19. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis.
Hei N; Chen Y; Peng S; Bao Y; Jin L
Arch Oral Biol; 2022 Dec; 144():105567. PubMed ID: 36265392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
